April 24, 2020 at 08:50PM Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products

Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products, Draft Guidance, Level 1, CBER, CDER Biologics, Drugs, September 2019

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/2M6ENT4